Co-Diagnostics, Inc.
CODX
$1.55
$0.021.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 418.20K | 507.90K | 569.40K | 567.60K | 770.00K |
| Total Other Revenue | 204.30K | 0.00 | 434.30K | 2.93M | 3.15M |
| Total Revenue | 622.50K | 507.90K | 1.00M | 3.50M | 3.92M |
| Cost of Revenue | 222.40K | 335.10K | 606.20K | 786.20K | 999.10K |
| Gross Profit | 400.10K | 172.90K | 397.50K | 2.71M | 2.92M |
| SG&A Expenses | 11.44M | 15.66M | 18.62M | 19.59M | 20.64M |
| Depreciation & Amortization | 1.11M | 1.20M | 1.28M | 1.33M | 1.38M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.91M | 36.04M | 39.76M | 41.87M | 44.00M |
| Operating Income | -31.28M | -35.53M | -38.75M | -38.37M | -40.08M |
| Income Before Tax | -48.51M | -33.33M | -35.95M | -35.81M | -37.58M |
| Income Tax Expenses | -1.62M | -1.15M | 38.30K | 46.60K | 57.40K |
| Earnings from Continuing Operations | -46.90 | -32.18 | -35.99 | -35.86 | -37.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.90M | -32.18M | -35.99M | -35.86M | -37.64M |
| EBIT | -31.28M | -35.53M | -38.75M | -38.37M | -40.08M |
| EBITDA | -30.18M | -34.33M | -37.47M | -37.05M | -38.70M |
| EPS Basic | -32.38 | -29.44 | -34.31 | -34.88 | -37.19 |
| Normalized Basic EPS | -15.50 | -20.24 | -22.87 | -22.92 | -24.19 |
| EPS Diluted | -32.67 | -29.79 | -34.59 | -35.15 | -37.31 |
| Normalized Diluted EPS | -15.50 | -20.24 | -22.87 | -22.92 | -24.19 |
| Average Basic Shares Outstanding | 5.32M | 4.46M | 4.22M | 4.12M | 4.04M |
| Average Diluted Shares Outstanding | 5.32M | 4.46M | 4.22M | 4.12M | 4.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |